Saturday, May 14

Overall Congress Learning Objectives:

Following the program, participants will be able to:

Describe the latest approaches to diagnosis and treatment of Heart Failure due to Preserved EF (communicator, leader)
Understand clinical scenarios for consideration of special cardiomyopathies (scholar, medical expert)
Use practical and efficient approaches to treatment of HF due to Reduced EF (collaborator, professional)
Describe novel drugs and devices for treatment of heart failure (communicator, health advocate)

Please note that all times are set to Eastern Time (ET) (UTC-4)

8:00 a.m.	Breakfast Buffet Opens
8:30 - 9:30 a.m. ET	BREAKFAST SYMPOSIUM (unaccredited)
PLENARY SESSION 3: Canadian Heart Failure Society (CHFS) & Heart Failure Association of the ESC (HFA) Joint Plenary Session PREVENTING RECURRENT HOSPITALIZATIONS		CO-CHAIRS: Shelley Zieroth, MD (CHFS) Andrew Coats, MD (President, HFA)
9:40 a.m.	Plenary Opening Remarks	Shelley Zieroth, MD
9:55 a.m.	Worsening HF: What is it and Why is it Important?	Ovidiu Chioncel, MD
10:10 a.m.	Diuretics and 'New' Drugs in AHF	Peter Liu, MD
10:25 a.m.	Managing AF in Acute HF	Katia Dyrda, MD
10:40 a.m.	Identifying the 'Sweet Spot' for Invasive Hemodynamic Monitoring	Finn Gustafsson, MD
10:55 a.m.	Plenary Q&A
SÉANCE PLÉNIÈRE 3: PRÉVENIR LES HOSPITALISATIONS RÉCURRENTES		CO-PRÉSIDENTS: Kim Anderson, MD Serge Lepage, MD
9:40 a.m.	Mots de bienvenue	Serge Lepage, MD
9:55 a.m.	Détérioration clinique de l’insuffisance cardiaque : pathophysiologie et importance clinique	Mathieu Bernier, MD
10:10 a.m.	Approche à l’insuffisance cardiaque aiguë : Diurétique et nouvelles avenues de traitement	Normand Racine, MD
10:25 a.m.	Prise en charge de la FA en ADHF	Jean-François Roux, MD
10:40 a.m.	Utilisation judicieuse du monitoring invasif	Catherine Bourque, MD
10:55 a.m.	Questions-réponses en plénière
11:15 a.m.	BREAK (for in person delegates)
11:20 - 11:40 a.m.	CORRIDOR CONSULTS (for online delegates) Unaccredited – Choose to Attend one of our Engaging Faculty-Lead Sessions
WORKSHOPS Choose one to Attend
11:45 a.m. - 12:30 p.m.	1. Special Cardiomyopathies: Focus on Treatment	Margot Davis, MD Michael McDonald, MD Robert McKelvie, MD
11:45 a.m. - 12:30 p.m.	2. Treatment of Refractory HF	Jennifer Amadio, MD Stephanie Poon, MD
11:45 a.m. - 12:30 p.m.	3. Managing Depression in Heart Failure	Heather Tulloch, MD Karen Harkness, RN, PhD
11:45 a.m. - 12:30 p.m.	4. Practically Starting and Stopping GDMT	Jacinthe Boulet, MD Emmanuelle Ménard-Massie, MD
12:30 p.m.	Lunch Buffet Opens
12:50 - 1:50 p.m.	LUNCH SYMPOSIUM (unaccredited)
PLENARY 4: Canadian Heart Failure Society (CHFS) & Heart Failure Society of America (HFSA) Joint Plenary Session CUTTING EDGE HF THERAPIES		CO-CHAIRS Anique Ducharme, MD (President, CHFS) Mark Drazner, MD (President, HFSA)
2:00 p.m.	Presentation of Awards: CHFN & Trainee Research Competition	Jonathan Howlett, MD Anique Ducharme, MD
2:10 p.m.	Plenary Opening Remarks	Anique Ducharme, MD
2:15 p.m.	Has COVID-19 Taught us Anything about HF?	Anuradha Lala-Trinidade, MD
2:30 p.m.	New Devices for HF	Akshay S. Desai, MD
2:45 p.m.	Successes and Challenges with Percutaneous Valve Therapy	Anita Asgar, MD
3:00 p.m.	Challenges with ''Destination Therapy" in Canada	Nakul Sharma, MD
3:15 p.m.	Plenary Q&A
3:35 p.m.	Congress Closing Remarks	Shelley Zieroth, MD
3:45 - 4:05 p.m.	Day 2 Highlights From our Co-Chairs	Jonathan Howlett, MD Serge Lepage, MD Shelley Zieroth, MD

Overall Congress Learning Objectives:

PLENARY SESSION 3:

SÉANCE PLÉNIÈRE 3:

WORKSHOPS

PLENARY 4:

Follow @CanHFSociety Along on Twitter